Clinical Trial Detail

NCT ID NCT02828124
Title A Study of the Safety and Tolerability of BMS-986183 in Patients With Liver Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

liver cancer

Therapies

BMS-986183

BMS-986183 + Nivolumab

Age Groups: adult senior

No variant requirements are available.